l e t t e r s
Meier-Gorlin syndrome (ear, patella and short-stature syndrome) is an autosomal recessive primordial dwarfism syndrome characterized by absent or hypoplastic patellae and markedly small ears [1] [2] [3] . Both pre-and post-natal growth are impaired in this disorder, and although microcephaly is often evident, intellect is usually normal in this syndrome. We report here that individuals with this disorder show marked locus heterogeneity, and we identify mutations in five separate genes: ORC1, ORC4, ORC6, CDT1 and CDC6. All of these genes encode components of the pre-replication complex, implicating defects in replication licensing as the cause of a genetic syndrome with distinct developmental abnormalities.
In the accompanying paper 4 , we identified mutations in ORC1 encoding a subunit of the origin recognition complex (ORC) in five individuals with microcephalic primordial dwarfism. The ORC multi protein complex is loaded onto chromatin at DNA origins before the S phase in order to license replication. In conjunction with addi tional components CDT1, CDC6 and minichromosome maintenance (MCM) helicase proteins, it then forms the prereplication complex (described in Fig. 1 ). Cellular studies have established that individuals with ORC1 mutations (called here ORC1 cases) had partial lossof function defects in replication licensing 4 . An orc1 zebrafish model recapitulated the dwarfism phenotype, as did morpholino depletion of another prereplication complex component, mcm5. This led us to hypothesize that further prereplication complex genes might cause primordial dwarfism; however, we did not find mutations in other ORC subunits.
In this study, the profound growth retardation and microcephaly in an individual with a complex lethal developmental syndrome led us to screen him for ORC1 mutations. We found that this individual and his brother (called here P1 and P2; Table 1 and Supplementary Table 1) were compound heterozygote for mutations in ORC1 (p.Arg105Gln and p.Val667fsX24). The combination of truncating and missense mutations present in these individuals was in contrast to biallelic missense mutations seen in previous ORC1 cases, suggestive of greater lossoffunction and consistent with a more severe phenotype. Unlike previous ORC1 cases, the proband (P1) had an extensive number of developmental malformations including severe cortical dysplasia, congenital emphysema, absence of the pancreatic tail and retroflexion of the knees, as well as micropenis, blepharophimosis and cranial suture stenosis (Fig. 1) . Notably, he also had marked microtia and absent patellae, features classically associated with MeierGorlin syndrome (MIM224690).
Consequently, we sequenced ORC1 in 33 individuals with an established diagnosis of MeierGorlin syndrome and identified two further cases with mutations in ORC1 ( Table 1 and Fig. 2 ). Both individuals, from families 2 and 3, respectively, were compound heterozygotes for the same ORC1 mutations: a splice acceptor site mutation in conjunction with the previously identified c.314G>A l e t t e r s Figure 1 The pre-replication complex and MeierGorlin syndrome. (a) Genome replication is licensed by the binding of a number of specialized proteins to origins of replication that then form the pre-replication complex 9 . The first step in complex formation is the loading of the heterohexameric origin recognition complex (comprising ORC1-6 proteins) onto chromatin in an ATP-dependent manner during the M and G1 phases of the cell cycle. Further proteins, including CDC6 and CDT1, are then recruited to the pre-replicative complex that then permit reiterative loading of the multimeric MCM helicase. At the commencement of the S phase, replication is started by the MCM helicase unwinding the DNA and the recruitment of additional replication proteins. The five proteins implicated in Meier-Gorlin syndrome are highlighted in white text (ORC1, ORC4, ORC6, CDT1 and CDC6). mutation that encodes the p.Arg105Gln amino acid substitution 4 , again in contrast to the biallelic missense mutations observed in the previous study. In family 2, the c.314G>A mutation was inherited on a haplotype shared with family 1 (Supplementary Fig. 1 ), consistent with common ancestry. However, the c.314G>A mutation in family 3 and the two splice acceptor site mutations in families 2 and 3
Pre-replication complex Mutations are described numbered from the first nucleotide of the initiation codon in the nucleotide sequence. For each mutation, 380 control chromosomes were screened and found to be negative for the sequence change. The protein truncation p.Tyr520X in CDT1 is within the last exon and therefore the transcript is not expected to undergo nonsense-medicated mRNA decay. Additionally, in CDT1, the mutation c.351G>C confers a non-conservative amino acid substitution (p.Gln117His), however, the nucleotide lies within the exon 2 splice donor site, and therefore this mutation is expected to result in an inframe deletion of exon 3 from the transcript and resulting protein. Table 1) . We found monozygotic twins P6 and P7 to be homozygous for a missense mutation (c.521A>G, p.Tyr174Cys) in ORC4 (this family is also reported in reference 5, having been independ ently ascertained). The substituted tyrosine was conserved through out evolution in organisms as distant as Saccharomyces cerevisiae and Schizosaccharomyces pombe and was located within box VI of the ATPase associated with a wide range of cellular activities (AAA) domain 6 (Fig. 2) , a domain that is essential for ATPdependent complex formation of ORC4 with other ORC subunits 7, 8 . A second individual, P5, is a com pound heterozygote for this same p.Tyr174Cys substitution (present on the ancestral haplotype shared with P6 and P7; Supplementary Fig. 1 ) in conjunction with a 4bp insertion mutation causing a translational frameshift and premature protein termination.
In family 6, three affected children were compound heterozygotes for mutations in ORC6. Similar to P5, these children inherited one lossoffunction mutation caused by a 2bp deletion and a missense mutation resulting in the substitution (p.Tyr232Ser) of an amino acid completely conserved from fungi to humans located at the C terminus of the ORC6 protein (Fig. 2) .
Given that mutations in genes encoding multiple components of the ORC complex cause MeierGorlin syndrome, we next examined whether additional components of the prereplication complex could be similarly implicated. CDT1 and CDC6 are recruited to the pre replication complex following assembly of the full ORC complex on chromatin 9 . As the region mutated in ORC6 is involved in CDT1 protein binding in S. cerevisiae 10 , we next screened our MeierGorlin-syndrome cohort for mutations in CDT1. We identified five families with compound heterozygous muta tions in CDT1 ( Table 1) . In three of these families, one of the mutations was c.1385G>A, causing the substitution p.Arg462Gln in the Cterminal winged helix domain of CDT1 (Fig. 2) . This residue has been implicated in MCM helicase complex binding through mutagenesis of the orthologous mouse resi due (p.Arg474Gln) 11 , the same aminoacid substitution resulting from the human muta tion we have identified here.
Finally, screening of CDC6 identified one individual with MeierGorlin syndrome (P18) homozygous for a missense mutation (c.968C>G) resulting in the substitution p.Thr323Arg. This residue is absolutely conserved from fungi to humans (Fig. 2) and lies within the box VII motif of the AAA domain (Fig. 2) 6 , an ATP binding domain that is essential for CDC6 function in DNA replication 12 .
We report here that mutations in multiple components of the pre replication complex cause MeierGorlin syndrome and, despite finding marked genetic heterogeneity, identify an underlying functional homo geneity in this disorder. The functional studies of ORC1 in the accompany ing manuscript 4 establish that impairment of ORC1 function is associated with extreme growth failure in humans. Here our molecular genetic find ings implicate the entire prereplication complex in primordial dwarfism syndromes, providing compelling genetic evidence supporting the notion that impaired replication licensing causes growth failure.
Though most of the affected individuals described in this paper have typical features of MeierGorlin syndrome 1-3 , we saw considerable phenotypic variation from mutations in these genes, particularly with the ORC1 cases reported here and in the accompanying paper 4 . Growth parameters vary markedly (height ranges from −0.4 to −9.6 stand ard deviations (s.d.) and head circumference from +1.7 to −9.8 s.d. from the population mean) with cognition varying from normal to severe neurological impairment associated with a severe cortical dysplasia. Thus, although microtia and small patellae are the best predictors of mutations in the prereplication complex, the disease spectrum associated with these genes could extend from cases described as microcephalic osteodysplastic primordial dwarfism I or III to those with nonsyndromic primordial dwarfism (for further discussion of clinical phenotypes, see the Supplementary Note).
Impaired replication might be expected to affect growth of all tissues equally; therefore, it is noteworthy that specific tissues are disproportionately reduced in size, most readily apparent in the ears and patellae. Most strikingly, major congenital malformations 13 . The cellular mechanisms by which prereplication complex (preRC) components cause the specific developmental phenotypes reported here are not immediately evident. It may be that proliferation of certain cell types, such as chondrocytes in the ears and patellae, are particularly sensitive to reduced preRC function. Alternatively, these and the other developmental anomalies could result from other cellular functions of the preRC components, as has been found for individual ORC proteins 14 .
Previous primordial dwarfism genes have DNA damage response and centrosome functions [15] [16] [17] [18] [19] , whereas here we find mutations in genes involved in licensing of DNA replication origins. All are critical components required for cell cycle progression. Pathogenesis is therefore likely to be the result of impaired cellular proliferation, resulting in reduced cell number and consequently global growth failure. Although in this framework genes regulating replication are rational candidates for primordial dwarfism, it is most surpris ing to find specific congenital malformations occurring as the con sequence of mutations in the prereplication complex. This suggests an unanticipated link between the regulation of replication and development that warrants future investigation. 
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